RAB8B, Member RAS Oncogene Family (RAB8B) (C-Term) Peptid
Kurzübersicht für RAB8B, Member RAS Oncogene Family (RAB8B) (C-Term) Peptid (ABIN8109884)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- C-Term
-
Verwendungszweck
- RAB8B Peptide - C-terminal region
-
Sequenz
- FETLTCSSGT LRTLRLKIDD FNDELNKLLE EIEEKNPQLI IDTEKHHPWA
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-RAB8B Antibody (ARP59677_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- RAB8B (RAB8B, Member RAS Oncogene Family (RAB8B))
-
Hintergrund
-
Background Information: NALP proteins, such as NALP2, are characterized by an N-terminal pyrin (MIM 608107) domain (PYD) and are involved in the activation of caspase-1 (CASP1, MIM 147678) by Toll-like receptors (see TLR4, MIM 603030). They may also be involved in protein complexes that activate proinflammatory caspases (Tschopp et al., 2003 [PubMed 12563287]).
Alternative Symbols: FLJ38125
-
Molekulargewicht
- 120kDa
-
Gen-ID
- 51762
-
NCBI Accession
- NP_057614
-
UniProt
- Q92930
Target
-